NCT07825961Completed
Efficacy of Melatonin in the Treatment of Diabetic Nephropathy Compared With Folic Acid
A Comparative Clinical Study to Evaluate the Efficacy of Melatonin in the Treatment of Diabetic Nephropathy Compared With Folic Acid
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Brief summary (registry, in English)
The current study aims to investigate and compare the anti-inflammatory effects of melatonin versus folic acid in patients with diabetic nephropathy.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 75 (actual)
- First submitted
- 12 Sept 2026
- Start date
- 1 Apr 2025
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Tanta University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07825961
What you commit to
- Study type: Interventional
- Participants enrolled: 75
- From 1 Apr 2025 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who are expectant or breastfeeding.
- Have significant comorbidities.
- Have rapidly declining renal function.
- Have acute kidney injury.
Who the study is looking for
- Adults aged 18-75 years.
- Patients with a confirmed diagnosis of Type 2 diabetes and diabetic nephropathy, as indicated by an elevated urine albumin-to-creatinine ratio (UACR ≥ 30 mg/g) or a decreased estimated glomerular filtration rate (eGFR \< 60 mL/min/1.73 m²).
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tanta university Coordinator of this site? Confirm its status | Tanta | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.